Literature DB >> 7969280

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.

R Solomon1, C Werner, D Mann, J D'Elia, P Silva.   

Abstract

BACKGROUND: Injections of radiocontrast agents are a frequent cause of acute decreases in renal function, occurring most often in patients with chronic renal insufficiency and diabetes mellitus.
METHODS: We prospectively studied 78 patients with chronic renal insufficiency (mean [+/- SD] serum creatinine concentration, 2.1 +/- 0.6 mg per deciliter [186 +/- 53 mumol per liter]) who underwent cardiac angiography. The patients were randomly assigned to receive 0.45 percent saline alone for 12 hours before and 12 hours after angiography, saline plus mannitol, or saline plus furosemide. The mannitol and furosemide were given just before angiography. Serum creatinine was measured before and for 48 hours after angiography, and urine was collected for 24 hours after angiography. An acute radiocontrast-induced decrease in renal function was defined as an increase in the base-line serum creatinine concentration of at least 0.5 mg per deciliter (44 mumol per liter) within 48 hours after the injection of radiocontrast agents.
RESULTS: Twenty of the 78 patients (26 percent) had an increase in the serum creatinine concentration of at least 0.5 mg per deciliter after angiography. Among the 28 patients in the saline group, 3 (11 percent) had such an increase in serum creatinine, as compared with 7 of 25 in the mannitol group (28 percent) and 10 of 25 in the furosemide group (40 percent) (P = 0.05). The mean increase in serum creatinine 48 hours after angiography was significantly greater in the furosemide group (P = 0.01) than in the saline group.
CONCLUSIONS: In patients with chronic renal insufficiency who are undergoing cardiac angiography, hydration with 0.45 percent saline provides better protection against acute decreases in renal function induced by radiocontrast agents than does hydration with 0.45 percent saline plus mannitol or furosemide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969280     DOI: 10.1056/NEJM199411243312104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  155 in total

Review 1.  2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician.

Authors:  Nanette K Wenger
Journal:  Clin Cardiol       Date:  2011-12-06       Impact factor: 2.882

2.  Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.

Authors:  Paolo Calabrò; Renatomaria Bianchi; Mario Crisci; Mario Caprile; Maurizio Cappelli Bigazzi; Rosalinda Palmieri; Enrica Golia; Anna De Vita; Ilaria Jane Romano; Giuseppe Limongelli; Maria Giovanna Russo; Raffaele Calabrò
Journal:  Intern Emerg Med       Date:  2011-01-29       Impact factor: 3.397

Review 3.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 4.  Just the berries: Nephrotoxic drugs.

Authors:  Tom Hewlett
Journal:  Can Fam Physician       Date:  2004-05       Impact factor: 3.275

5.  Radiocontrast-induced acute kidney injury in the ICU: worse than presumed?

Authors:  Michael Joannidis; Christian J Wiedermann
Journal:  Intensive Care Med       Date:  2011-11-03       Impact factor: 17.440

Review 6.  [Combined use of contrast media containing iodine and gadolinium for imaging and intervention : A hitherto widely ignored topic in radiological practice].

Authors:  W Golder
Journal:  Radiologe       Date:  2012-02       Impact factor: 0.635

Review 7.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

Review 8.  [Complications due to contrast agent administration: what has been confirmed in prevention?].

Authors:  E Schönenberger; M Mühler; M Dewey
Journal:  Internist (Berl)       Date:  2010-12       Impact factor: 0.743

9.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

10.  Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography.

Authors:  Po-Tsang Lee; Kang-Ju Chou; Hua-Chang Fang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.